Biguanides are classed as non-sulfonylureas. Metformin is the only available biguanide for diabetes treatment. It inhibits the amount of glucose produced by the liver, increases the insulin-receptor binding and stimulates tissue uptake of glucose. Metformin does not stimulate the pancreas to make or release more insulin so doesn't cause hypoglycemia.
By clicking Subscribe, I agree to the Drugs.com Terms & Conditions & Privacy Policy and understand that I may opt out of Drugs.com subscriptions at any time.
